Showing results (191-200 of 420) with videos related to

Sort By:
Pageof 42
Advances in Therapy|July 4, 2019
A Randomized, Double-Blind, Double-Dummy Study of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Relative to Umeclidinium/Vilanterol Dry Powder Inhaler in COPDFrançois Maltais, Gary T Ferguson, Gregory J Feldman, et al.
The Lancet. Respiratory Medicine|October 2, 2025
Reframing remission in severe asthma: a conceptual framework for distinguishing disease activity versus damageCeleste Porsbjerg, Hitasha Rupani, John D Brannan, et al.
The Lancet. Respiratory Medicine|August 2, 2015
Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trialChristopher E Brightling, Pascal Chanez, Richard Leigh, et al.
Respirology (Carlton, Vic.)|December 17, 2013
Association of chronic nasal symptoms with dyspnoea and quality-of-life impairment in chronic obstructive pulmonary diseaseDenis Caillaud, Pascal Chanez, Roger Escamilla, et al.
ERJ Open Research|September 23, 2020
Response to mepolizumab treatment is sustained across 4-weekly dosing periodsIan D Pavord, Eugene R Bleecker, Roland Buhl, et al.
The European Respiratory Journal|March 17, 2017
Early computed tomography modifications following bronchial thermoplasty in patients with severe asthmaMarie-Pierre Debray, Marie-Christine Dombret, Marina Pretolani, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
IL-33 receptor inhibition in subjects with uncontrolled asthma: A randomized, placebo-controlled trialCourtney Crim, Sally Stone, Valerie Millar, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 23, 2018
Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiencyJeanne Marie Perotin, Sylvie Leroy, Charles Hugo Marquette, et al.
Plos One|September 5, 2008
Airway and esophageal stenting in patients with advanced esophageal cancer and pulmonary involvementFabrice Paganin, Laurent Schouler, Laurent Cuissard, et al.
Stem Cell Research|October 9, 2018
Generation of the induced pluripotent stem cell line UHOMi001-A from a patient with mutations in CCDC40 gene causing Primary Ciliary Dyskinesia (PCD)Engi Ahmed, Caroline Sansac, Mathieu Fieldes, et al.
Pageof 42